• When a Statement Becomes a Promise: Canadian Federal Court of Appeal Studies “Promise Doctrine” In Celecoxib Patent Utility Finding
  • March 27, 2015 | Author: Jason Moscovici
  • Law Firm: ROBIC, LLP - Montreal Office
  • On October 30th, 2014, the Canadian Federal Court of Appeal dismissed two appeals brought by Mylan Pharmaceuticals ULC and Apotex Inc. ("Appellants"), heard jointly, in a decision that further clarifies the “promise doctrine” applied to patent validity cases involving the evaluation of utility.